no statement of use filed
on 11 Apr 2022
Last Applicant/ Owned by
125 Cambridgepark Drive
Cambridge
MA
02140
Serial Number
87770621 filed on 25th Jan 2018
Registration Number
N/A
Correspondent Address
Ann Lamport Hammitte
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
Medicated gels for therapeutic use in the nature of therapeutic pharmaceuticals containing ammonia oxidizing bacteria for the treatment of inflammatory diseases, for the treatment of systemic diseases, namely, hypertension, other cardiovascular and circulatory disorders, and primary and secondary headache disorders including migraine, and to counteract skin damage caused by UV exposure or aging; mRead More
Medicated gels for therapeutic use in the nature of therapeutic pharmaceuticals containing ammonia oxidizing bacteria for the treatment of inflammatory diseases, for the treatment of systemic diseases, namely, hypertension, other cardiovascular and circulatory disorders, and primary and secondary headache disorders including migraine, and to counteract skin damage caused by UV exposure or aging; medicated creams for therapeutic use in the nature of therapeutic pharmaceuticals containing ammonia oxidizing bacteria for the treatment of inflammatory diseases, for the treatment of systemic diseases, namely, hypertension, other cardiovascular and circulatory disorders, and primary and secondary headache disorders including migraine, and to counteract skin damage caused by UV exposure or aging; medicated sprays for therapeutic use in the nature of therapeutic pharmaceuticals containing ammonia oxidizing bacteria for the treatment of inflammatory diseases, for the treatment of systemic diseases, namely, hypertension, other cardiovascular and circulatory disorders, and primary and secondary headache disorders including migraine, and to counteract skin damage caused by UV exposure or aging; nasal sprays for therapeutic use; topical applications in the nature of gels, creams, sprays, and liquids for therapeutic use, namely, topical preparations containing ammonia oxidizing bacteria for the treatment of skin disorders, acne, inflammation, eye disorders, migraines, headaches, allergic reactions, insomnia, hypertension, thermoregulation, and to promote wound healing; medicated liquids for therapeutic use in the nature of therapeutic pharmaceuticals for the treatment of inflammatory diseases, for the treatment of systemic diseases, namely, hypertension, other cardiovascular and circulatory disorders, and primary and secondary headache disorders including migraine, and to counteract skin damage caused by UV exposure or aging; biological therapeutics being pharmaceutical preparations for treatment of skin disorders, circulatory and cardiovascular disorders, neurologic diseases, inflammation, gastrointestinal disorders, respiratory disorders, eye disorders, urogenital disorders, auditory disorders, migraines, headaches, allergic rhinitis, insomnia, hyperhidrosis, acne, and hypertension; therapeutic agents for thermoregulation and promoting wound healing
Stents; intra-uterine contraceptive devices; catheters; pessaries; coatings sold as an integral component of medical stents and other implantable medical devices
No 87770621
No Service/Collective Mark
No N2060-2007
No
No
No
No
No
No
No
No
| Status Date | Action Taken |
|---|---|
| 11th Apr 2022 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
| 11th Apr 2022 | ABANDONMENT - NO USE STATEMENT FILED |
| 19th Aug 2021 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 18th Aug 2021 | EXTENSION 5 GRANTED |
| 18th Aug 2021 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| 16th Aug 2021 | EXTENSION 5 FILED |
| 16th Aug 2021 | TEAS EXTENSION RECEIVED |
| 11th Feb 2021 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 09th Feb 2021 | EXTENSION 4 GRANTED |
| 09th Feb 2021 | EXTENSION 4 FILED |
